A critical combination for Alzheimer's patients

Alzheimer’s disease is an irreversible, progressive brain disorder that destroys memory and other critical brain functions. It is the sixth leading cause of death among adults. As scientists actively research a cure, patients and families are managing the disease’s devastating effects. At Barrow, our dedicated doctors and scientists provide hope to patients and caregivers battling the disease by integrating research with compassionate care. See what we achieved in 2019 by downloading the Impact Report below.

By combining cutting edge research with high quality care, we can make Alzheimer’s a manageable condition, rather than a death sentence, within ten years. Give now.

Changing the lives of patients with Alzheimer’s and memory disorders

At Barrow we are uniquely positioned to lead research into new Alzheimer’s treatments due to our strong research culture, critical mass of talented faculty and infrastructure focused on innovative studies.

Our team is driven by a passion for the cause. Elliott Mufson, PhD, a highly respected Alzheimer’s Disease researcher, lost his father to the condition and has since committed his work to identifying its causes. He is a pioneer in the application of single cell gene array technology during the disease’s progression, with his research leading to a clinical trial aimed at rejuvenating brain cells lost early in the development of Alzheimer’s.